IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Montana

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Montana $ 1,296,971.19
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Ateris Technologies, LLC Organophosphate poisoning detection and diagnostic systems $ 244,479.25  
Bacterin International, Inc Antimicrobial Orthopedic Surgical Fixation Devices $ 7,500.00 $ 236,979.25
Genectar Com LLC New therapy for metastatic melanoma through expanded comparative genomics. $ 7,836.53 $ 13,343.30
LigoCyte Pharmaceuticals, Inc Development of a Vaccine for the Prevention of Human Norovirus Acute Gastroenteritis $ 244,479.25  
LigoCyte Pharmaceuticals, Inc. Development of a Novel Virus-like Particle Based Respiratory Syncytial Virus Vaccine $ 244,479.25  
Microbin Corporation A Novel, Broad-Spectrum Antimicrobial Therapeutic for Treatment of infectious Diseases $ 113,575.50 $ 130,903.75
NanoValent Pharmaceuticals, Inc. Drug delivery system to treat cancer $ 9,712.11 $ 13,500.00
SensoPath Technologies, Inc Targeted Two-photon Photodynamic Therapy Drugs for Treatment of cancer $ 13,730.50 $ 16,452.50

References/Related Topics

Page Last Reviewed or Updated: 31-Mar-2014